Nov 7 Statement | UMR Congratulates Dr. Monica Bertagnolli on her Confirmation as the next NIH Director
NIH Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
2023 Rural State Analysis | UMR's Newest Report Reveals the Exponential Impact of NIH Research Funding in Rural States
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Scientific progress toward treatment and prevention measures for COVID-19

Since the early days of the outbreak, Johnson & Johnson has been working with industry partners, governments and health authorities to help end the fast-moving COVID-19 pandemic through the development of a possible preventive vaccine candidate against SARS-CoV-2. Our scientists are simultaneously reviewing known pathways in coronavirus pathophysiology to determine whether previously tested medicines can be used to help patients survive COVID-19 and reduce the severity of disease in non-lethal cases.